These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18051432)

  • 1. [Synthetic small molecules that control stem cell fate].
    Kawazoe Y
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1800-1. PubMed ID: 18051432
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycogen synthase kinase 3beta (GSK3beta) regulates differentiation and proliferation in neural stem cells from the rat subventricular zone.
    Maurer MH; Brömme JO; Feldmann RE; Järve A; Sabouri F; Bürgers HF; Schelshorn DW; Krüger C; Schneider A; Kuschinsky W
    J Proteome Res; 2007 Mar; 6(3):1198-208. PubMed ID: 17330951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency.
    Higuchi Y; Nguyen C; Yasuda SY; McMillan M; Hasegawa K; Kahn M
    Curr Mol Pharmacol; 2016; 9(3):272-279. PubMed ID: 26008738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering small molecules to control stem cell fate.
    Andrews PD
    Future Med Chem; 2011 Sep; 3(12):1539-49. PubMed ID: 21882946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ESI-MS/MS method for screening of small-molecule mixtures against glycogen synthase kinase-3beta (GSK-3beta).
    Partserniak I; Werstuck G; Capretta A; Brennan JD
    Chembiochem; 2008 May; 9(7):1065-73. PubMed ID: 18348127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evolutionary conserved role of Wnt signaling in stem cell fate decision.
    Teo R; Möhrlen F; Plickert G; Müller WA; Frank U
    Dev Biol; 2006 Jan; 289(1):91-9. PubMed ID: 16309665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of small molecule compounds inducing differentiation of stem cells].
    Li X; Shan L; Li WL; Zhang SD; Zhang WD
    Yao Xue Xue Bao; 2011 Feb; 46(2):121-6. PubMed ID: 21542280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
    Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
    Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic small molecules that control stem cell fate.
    Ding S; Wu TY; Brinker A; Peters EC; Hur W; Gray NS; Schultz PG
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7632-7. PubMed ID: 12794184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assisted birth with DISC1.
    Welberg L
    Nat Rev Neurosci; 2009 May; 10(5):314. PubMed ID: 19382320
    [No Abstract]   [Full Text] [Related]  

  • 12. Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.
    Duinhouwer LE; Tüysüz N; Rombouts EW; Ter Borg MN; Mastrobattista E; Spanholtz J; Cornelissen JJ; Ten Berge D; Braakman E
    PLoS One; 2015; 10(3):e0119086. PubMed ID: 25807521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
    Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
    Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Trk and G Protein Signalings Regulate Dopaminergic Neurodifferentiation in Human Trophoblast Stem Cells.
    Tsai EM; Wang YC; Lee TT; Tsai CF; Chen HS; Lai FJ; Yokoyama KK; Hsieh TH; Wu RM; Lee JN
    PLoS One; 2015; 10(11):e0143852. PubMed ID: 26606046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of FGF2 signaling determines whether beta-catenin exerts effects on proliferation or neuronal differentiation of neural stem cells.
    Israsena N; Hu M; Fu W; Kan L; Kessler JA
    Dev Biol; 2004 Apr; 268(1):220-31. PubMed ID: 15031118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dishevelled promotes neurite outgrowth in neuronal differentiating neuroblastoma 2A cells, via a DIX-domain dependent pathway.
    Fan S; Ramirez SH; Garcia TM; Dewhurst S
    Brain Res Mol Brain Res; 2004 Dec; 132(1):38-50. PubMed ID: 15548427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin.
    Wu X; Quondamatteo F; Lefever T; Czuchra A; Meyer H; Chrostek A; Paus R; Langbein L; Brakebusch C
    Genes Dev; 2006 Mar; 20(5):571-85. PubMed ID: 16510873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
    Castelo-Branco G; Rawal N; Arenas E
    J Cell Sci; 2004 Nov; 117(Pt 24):5731-7. PubMed ID: 15522889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical biology in stem cell research.
    Choi Y; Nam TG
    Arch Pharm Res; 2012 Feb; 35(2):281-97. PubMed ID: 22370782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells.
    Etheridge SL; Spencer GJ; Heath DJ; Genever PG
    Stem Cells; 2004; 22(5):849-60. PubMed ID: 15342948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.